Vascularized models exhibit significantly higher metabolic activity than non-vascularized versions, including increased albumin secretion, urea production, and bilirubin clearance—reaching levels comparable to those found in human blood
3D Bioprinted Liver Tissue
Project: “3D Bioprinted Liver Tissue with Vascular System as an Innovative Model for Drug Toxicity Assessment and Anti-Cancer Therapy Efficacy,” co-financed by the European Union from the European Regional Development Fund, Operational Programme Intelligent Development 2014-2020. The project is being implemented as part of the National Centre for Research and Development competition 3/1.1.1/2020 Fast Track 3_2020.
Demo Request